Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06335823
Other study ID # STUDY20231621
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 5, 2024
Est. completion date August 1, 2025

Study information

Verified date June 2024
Source University Hospitals Cleveland Medical Center
Contact Jean M Marino, APRN-CNP
Phone 440-720-3250
Email Jean.Marino@UHhospitals.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information gleaned from this study will result in pain control options for future patients who desire an IUD placement.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date August 1, 2025
Est. primary completion date August 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Age 18-45 years old - Individuals with a cervix and uterus - Seeking intrauterine device (IUD) placement for contraception or management of abnormal uterine bleeding - Meet medical eligibility for IUD placement - Ability to consent in English - Ability to use the visual analogue scale (VAS) Exclusion Criteria: - Contraindications to IUD placement - Use of analgesics within the last 4 hours prior to IUD placement - Presence of a pacemaker

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Transcutaneous electrical nerve stimulation (TENS)
All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients will have the TENS unit turned on and half will have the TENS unit turned on to a 80 hz preset frequency with 100 mA as the pulse width.
Placebo Transcutaneous electrical nerve stimulation (TENS)
All patients will have the TENS unit applied: 2 pads from channel 1 will be at T10-L1 and the second set of pads will be from S2-S4; 5 minutes prior to the start of the procedure. Patients will have the TENS unit will not be turned on.

Locations

Country Name City State
United States University Hospitals Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
Jean Marino

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable baseline
Primary Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable IUD placement/introducer removal up to 5 minute
Secondary Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable speculum placement up to 1 minute
Secondary Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable tenaculum placement up to 1 minute
Secondary Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable sound insertion up to 5 minute
Secondary Pain during IUD insertion as measured by the VAS score The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable 5 minute post IUD insertion
See also
  Status Clinical Trial Phase
Completed NCT04079140 - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion Phase 4
Not yet recruiting NCT04301349 - Dinoprostone vs Misoprostol Before LNG-IUD Insertion Phase 3
Completed NCT03499743 - Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD. N/A
Completed NCT04312048 - the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion Phase 3